ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose - solution for inhalation - 2.5 mcg/dose - active: tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiriva respimat is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - ipratropium bromide - inhaler - ipratropium bromide 0.02 mg - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation; tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation - solution for inhalation - 2.5mcg/2.5mcg - active: olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiolto respimat is indicated for the long term, once daily maintenance treatment in patients with copd (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, and to reduce associated dyspnoea.

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - nintedanib as esilate - capsules soft - nintedanib as esilate 100 mg - idiopathic pulmonary fibrosis ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf) in adults. systemic sclerosis-associated interstitial lung diseaseofev is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (ssc-ild).chronic fibrosing interstitial lung diseases with a progressive phenotypeofev is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - nintedanib as esilate - capsules soft - nintedanib as esilate 150 mg - idiopathic pulmonary fibrosis ofev is indicated for the treatment of idiopathic pulmonary fibrosis (ipf) in adults. systemic sclerosis-associated interstitial lung diseaseofev is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (ssc-ild).chronic fibrosing interstitial lung diseases with a progressive phenotypeofev is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ilds) with a progressive phenotype

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - solution for inhalation - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide - spiolto respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - tiotropium bromide as monohydrate - solution for inhalation - tiotropium bromide as monohydrate 2.5 mcg - tiotropium bromide - maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).copd:tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).asthma:spiriva respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - capsules - dabigatran etexilate as mesilate 150 mg - dabigatran etexilate - prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

イスラエル - 英語 - Ministry of Health

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - capsules - dabigatran etexilate as mesilate 150 mg - dabigatran etexilate - prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - linagliptin, quantity: 5 mg; empagliflozin, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; mannitol; crospovidone; titanium dioxide; magnesium stearate; copovidone; pregelatinised maize starch; macrogol 6000; iron oxide red; maize starch - glyxambi tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).